MBXBF (MBXBF) Stock Price & Analysis
MBXBF (MBXBF) rose 5.16% to USD 0.23 as of September 8, 2026 at 22:18 UTC, according to Nexqual real-time market data.
MBXBF last closed at USD 0.23; the session ranged USD 0.23–0.23 on volume of 300 shares. Market capitalization is —, with a 52-week range of USD 0.15–0.23 (OQX). Source: Nexqual, September 8, 2026 at 22:18 UTC.
Key Statistics (as of September 8, 2026 at 22:18 UTC)
| Price | USD 0.23 |
|---|---|
| Change | ▲ 5.16% (up) |
| Previous Close | USD 0.23 |
| Open | USD 0.23 |
| Day Range | USD 0.23 – 0.23 |
| 52-Week Range | USD 0.15 – 0.23 |
| Volume | 300 shares |
| Market Cap | — |
| Exchange | OQX |
Technical Analysis (MBXBF)
Nexqual's technical model rates MBXBF "NEUTRAL" based on 2 bullish and 3 bearish signals across 126 daily candles, as of September 8, 2026 at 22:18 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 52.7 (neutral) |
| vs SMA50 | Above (USD 0.22) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRBCF | Sirona Biochem Corp. | USD 0.01 | ▲ 0% |
| AVCNF | Avicanna Inc. | USD 0.08 | ▼ 5.88% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
| EMMA | Emmaus Life Sciences, Inc. | USD 0.06 | ▼ 1.63% |
| CVALF | Covalon Technologies Ltd. | USD 2.56 | ▲ 15.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 22:18 UTC. This page is informational and not investment advice.